Complete Starter Dose Cost Breakdown for Both Treatments
Wegovy vs Mounjaro Cost UK: Understanding Your Starter Options
When evaluating wegovy vs mounjaro cost uk for starter doses, the fundamental difference begins with each medication's unique approach to weight management. Wegovy contains semaglutide, a GLP-1 receptor agonist that works by mimicking your body's natural fullness hormone. Mounjaro contains tirzepatide, which acts as a dual agonist targeting both GIP and GLP-1 receptors. This difference in mechanism influences both the dosing schedules and associated costs throughout your treatment journey.
The starter dose for Wegovy is 0.25mg, administered once weekly for the first four weeks at £79.99. This initial dose allows your body to adapt to the medication whilst minimising potential side effects such as nausea or reduced appetite. Mounjaro follows its own escalation protocol with different starting doses and pricing structure. Both treatments require a prescription-only medicine assessment through our clinical team at EverydayMeds, ensuring you receive appropriate medical oversight from the beginning of your treatment.
Wegovy Starter Dose Pricing and Bundle Options for UK Patients
The wegovy vs mounjaro cost uk comparison for starter doses reveals several purchasing options designed to support new patients. Wegovy's 0.25mg starter dose costs £79.99 when using discount code FIRST40 for new customers, providing four weeks of treatment to begin your dose escalation safely. For patients planning ahead, our Intro Duo bundle combines the 0.25mg starter with the subsequent 0.5mg dose for £169.99, covering your first eight weeks. This approach ensures treatment continuity without requiring multiple orders during your initial adaptation period.
Our Gentle Start Trio at £269.99 includes two 0.25mg pens plus one 0.5mg pen, allowing patients who may need a slower progression through the initial doses. This bundle proves particularly valuable for those concerned about side effects or who prefer a more gradual introduction to semaglutide. Returning customers can use code DOSE25 at checkout, whilst all purchases include next-day cold-chain delivery once your prescription is approved by our clinical team.
Clinical Evidence Supporting Wegovy vs Mounjaro Cost UK Decisions
The STEP clinical trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved an average of approximately clinically studied weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). These results were observed when patients followed the complete 16-week dose escalation schedule, beginning with the 0.25mg starter dose. The gradual increase in dose strength helps optimise both effectiveness and tolerability throughout treatment.
Mounjaro's clinical evidence comes from the SURMOUNT trials, showing its own efficacy profile with the dual-hormone approach. When considering wegovy vs mounjaro cost uk for starter doses, both medications have demonstrated effectiveness in clinical settings when prescribed appropriately. Individual response may vary, and your prescriber will consider your medical history, current medications, and weight management goals when recommending either treatment option.
How Wegovy Works: Understanding the 0.25mg Starter Mechanism
Wegovy functions as a GLP-1 receptor agonist, closely mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines after eating. When you inject the 0.25mg starter dose, semaglutide binds to GLP-1 receptors in your brain, specifically in areas that control appetite and food intake. This binding action promotes feelings of satiety after smaller meals and may help reduce food cravings throughout the day. The medication also slows gastric emptying, meaning food remains in your stomach longer, contributing to prolonged feelings of fullness. Starting at 0.25mg allows these mechanisms to develop gradually, giving your body time to adjust whilst establishing the foundation for your weight management journey alongside a reduced-calorie diet and increased physical activity.
EverydayMeds Ordering Process for Wegovy vs Mounjaro Cost UK
Beginning your treatment through EverydayMeds involves a streamlined three-minute online clinical assessment designed to gather essential medical information for your prescriber's review. Our UK-registered prescribers evaluate your responses within three working days (or 24 hours with express service), ensuring appropriate clinical oversight before any medication is dispensed. Once approved, your Wegovy 0.25mg starter dose or chosen bundle ships via next-day delivery using temperature-controlled packaging to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) handles all aspects of dispensing and delivery, providing professional pharmaceutical care throughout your treatment. This integrated approach eliminates the need for separate GP appointments or multiple pharmacy visits when comparing wegovy vs mounjaro cost uk options.
Storage and Practical Considerations for Wegovy Starter Dose
Wegovy pens require refrigerated storage between 2-8°C before first use, but offer a significant practical advantage once removed from refrigeration. The medication remains stable at room temperature (below 30°C) for up to six weeks, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy particularly suitable for frequent travellers or those with unpredictable schedules. Each FlexTouch pen is pre-filled and ready for injection, with clear dose escalation guidance provided alongside your prescription. The 0.25mg starter dose prepares you for the systematic increase through 0.5mg, 1mg, 1.7mg, and finally 2.4mg maintenance dosing over 16 weeks, ensuring optimal therapeutic outcomes whilst managing tolerability.
Why Starter Dose Timing Matters in Wegovy vs Mounjaro Cost UK Planning
The wegovy vs mounjaro cost uk comparison for starter doses extends beyond simple price points to encompass treatment timeline and commitment requirements. Wegovy's 16-week escalation protocol means your total cost builds systematically from the £79.99 starter through to £209.99 for maintenance dosing. This graduated approach allows you to assess both tolerance and initial response before committing to higher-dose treatments. Planning your treatment timeline helps budget appropriately whilst ensuring you don't interrupt the medically-supervised dose escalation schedule.
Many patients find value in discussing bundle options during their initial consultation, as the Intro Duo or Intro Trio packages can simplify the early treatment phases. Your prescriber can advise whether a slower progression using multiple 0.25mg pens might be appropriate based on your medical history and previous experience with GLP-1 medications. This personalised approach ensures your wegovy vs mounjaro cost uk decision reflects both clinical suitability and practical considerations.
Complete Treatment Investment: From Starter to Maintenance
Understanding the full cost journey helps inform your wegovy vs mounjaro cost uk starter dose decision with complete transparency. Beginning with Wegovy's 0.25mg starter at £79.99, patients typically progress through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), before reaching £209.99 maintenance dosing. New customers benefit from the FIRST40 discount code, whilst returning customers use DOSE25 for ongoing savings. Our bundle options provide convenience and supply security, particularly valuable during the critical early weeks when establishing your treatment routine.
Each stage of dose escalation serves specific clinical purposes, making it inappropriate to skip doses or accelerate the schedule without medical supervision. The starter dose investment represents the foundation of your treatment journey, designed to optimise both safety and long-term effectiveness. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which option best suits your individual circumstances and treatment goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
